These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7716342)

  • 1. Lovastatin ameliorates depressed intraglomerular proteolytic activities in experimental nephrotic syndrome.
    Teschner M; Paczek L; Schaefer L; Bahner U; Heidland A; Schaefer RM
    Res Exp Med (Berl); 1994; 194(6):349-56. PubMed ID: 7716342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraglomerular proteinase activity in adriamycin-induced nephropathy.
    Paczek L; Teschner M; Schaefer RM; Kovar J; Romen W; Heidland A
    Nephron; 1992; 60(1):81-6. PubMed ID: 1738419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of lovastatin on the development of adriamycin nephropathy in rats].
    Tesar V; Zima T; Poledne R; Stejskalová A; Tĕmínová J; Stípek S
    Sb Lek; 1995; 96(1):35-42. PubMed ID: 8711364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of glomerular proteinases in the evolution of glomerulosclerosis.
    Schaefer RM; Paczek L; Huang S; Teschner M; Schaefer L; Heidland A
    Eur J Clin Chem Clin Biochem; 1992 Oct; 30(10):641-6. PubMed ID: 1493156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lovastatin ameliorates the development of glomerulosclerosis and uremia in experimental nephrotic syndrome.
    Harris KP; Purkerson ML; Yates J; Klahr S
    Am J Kidney Dis; 1990 Jan; 15(1):16-23. PubMed ID: 2294729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of renal disease on glomerular proteinases.
    Teschner M; Schaefer RM; Paczek L; Heidland A
    Miner Electrolyte Metab; 1992; 18(2-5):92-6. PubMed ID: 1465087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obese Zucker rat: potential role of intraglomerular proteolytic enzymes in the development of glomerulosclerosis.
    Teschner M; Paczek L; Schaefer RM; Heidland A
    Res Exp Med (Berl); 1991; 191(2):129-35. PubMed ID: 1857891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of disease on glomerular proteinases.
    Teschner M; Schaefer RM; Paczek L; Heidland A
    Przegl Lek; 1992; 49(1-2):1-5. PubMed ID: 1454996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lovastatin but not enalapril reduces glomerular injury in Dahl salt-sensitive rats.
    O'Donnell MP; Kasiske BL; Katz SA; Schmitz PG; Keane WF
    Hypertension; 1992 Nov; 20(5):651-8. PubMed ID: 1428116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lovastatin retards the progression of established glomerular disease in obese Zucker rats.
    O'Donnell MP; Kasiske BL; Kim Y; Schmitz PG; Keane WF
    Am J Kidney Dis; 1993 Jul; 22(1):83-9. PubMed ID: 8322799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of anti-hyperlipidaemic agent or dietary protein restriction on progressive renal deterioration in adriamycin-induced nephropathy in rats.
    Washio M; Nanishi F; Onoyama K; Okuda S; Fujishima M
    Int Urol Nephrol; 1993; 25(3):295-303. PubMed ID: 8225831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of chronic ethanol administration on adriamycin-induced nephrotic syndrome in rats.
    Tesar V; Zima T; Poledne R; Stejskalová A; Stípek S; Tĕmínová J
    Alcohol Alcohol; 1995 Jan; 30(1):47-53. PubMed ID: 7748275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lovastatin reduces glomerular macrophage influx and expression of monocyte chemoattractant protein-1 mRNA in nephrotic rats.
    Park YS; Guijarro C; Kim Y; Massy ZA; Kasiske BL; Keane WF; O'Donnell MP
    Am J Kidney Dis; 1998 Jan; 31(1):190-4. PubMed ID: 9428473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure.
    Kasiske BL; O'Donnell MP; Garvis WJ; Keane WF
    Circ Res; 1988 Feb; 62(2):367-74. PubMed ID: 3338121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of high-lipid diet on glomerular mesangial matrix in adriamycin-induced nephrotic rats.
    Song H; Li X; Wei M; Zhu C
    Chin Med Sci J; 2002 Sep; 17(3):134-9. PubMed ID: 12901534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of gelatinase (MMP-9) or collagenase (MMP-13) attenuates adriamycin-induced albuminuria and glomerulosclerosis.
    Sakamaki Y; Sasamura H; Hayashi K; Ishiguro K; Takaishi H; Okada Y; D'Armiento JM; Saruta T; Itoh H
    Nephron Exp Nephrol; 2010; 115(2):e22-32. PubMed ID: 20407279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrotic urine prevents increased rat glomerular albumin permeability induced by serum from the same patient with idiopathic nephrotic syndrome.
    Carraro M; Zennaro C; Candiano G; Musante L; Bruschi M; Ghiggeri GM; Artero M; Faccini L
    Nephrol Dial Transplant; 2003 Apr; 18(4):689-93. PubMed ID: 12637636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibition attenuates hypercholesterolemia and glomerular injury in hyperlipidemic Imai rats.
    Sakemi T; Baba N; Yoshikawa Y
    Nephron; 1992; 62(3):315-21. PubMed ID: 1436345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
    Grond J; Weening JJ; Elema JD
    Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of calcium(2+)/calmodulin-dependent protein kinase type IV ameliorates experimental nephrotic syndrome.
    Ao Q; Cheng Q; Ma Q; Wang X; Liu S
    Intern Med; 2013; 52(10):1035-41. PubMed ID: 23676587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.